Type 1 Diabetes in Pregnancy: CGM, Insulin, and Risk Management

Type 1 Diabetes and Pregnancy: What You Need to Know

Pregnancy is a transformative journey, but for women with Type 1 diabetes, it comes with unique challenges that require careful planning and expert medical support. The good news is that with modern technology, including continuous glucose monitors (CGMs) and advanced insulin therapies, women with Type 1 diabetes can have safe, healthy pregnancies. Understanding the tools and strategies available is the first step toward a successful outcome.

The Role of CGM During Pregnancy

Continuous glucose monitoring has revolutionized diabetes management during pregnancy. CGM devices provide real-time glucose readings every few minutes, allowing pregnant women and their healthcare teams to detect dangerous highs and lows quickly. During pregnancy, blood sugar targets become significantly tighter, making frequent monitoring essential.

The landmark CONCEPTT trial demonstrated that CGM use in pregnant women with Type 1 diabetes led to improved outcomes, including reduced rates of large-for-gestational-age babies and fewer neonatal intensive care unit admissions. Current guidelines from the American Diabetes Association (ADA) recommend CGM use throughout pregnancy for women with Type 1 diabetes.

Target glucose ranges during pregnancy are typically:

• Fasting and pre-meal: 70–95 mg/dL
• One hour after meals: Less than 140 mg/dL
• Two hours after meals: Less than 120 mg/dL

CGM alerts and alarms can notify women of glucose excursions, particularly overnight hypoglycemia, which is a common concern during the first trimester.

Insulin Management During Each Trimester

Insulin needs change dramatically across each trimester, requiring constant adjustment and collaboration with an endocrinologist and maternal-fetal medicine specialist.

First Trimester

Many women experience increased hypoglycemia during the first trimester due to nausea, vomiting, and changes in eating patterns. Insulin requirements may actually decrease during this period. Close monitoring and flexible dosing strategies are critical.

Second and Third Trimesters

As pregnancy progresses, hormones like cortisol, estrogen, and human placental lactogen increase insulin resistance significantly. Insulin doses may need to increase by 50–100% compared to pre-pregnancy levels. Insulin pumps (CSII) combined with CGM — often called a closed-loop or hybrid closed-loop system — have shown particular benefit, as they can automatically adjust basal insulin delivery in response to glucose trends.

After Delivery

Insulin sensitivity returns rapidly after delivery. Doses must be reduced immediately postpartum to avoid dangerous hypoglycemia. Breastfeeding can also lower blood glucose, requiring further dose adjustments.

Key Risks and How to Manage Them

Women with Type 1 diabetes face several pregnancy-related risks that require proactive management:

• Preeclampsia: Women with Type 1 diabetes have a higher risk of developing preeclampsia. Regular blood pressure monitoring and low-dose aspirin (as recommended by your doctor) can reduce this risk.
• Macrosomia: Elevated blood sugar exposes the baby to excess glucose, causing overgrowth. Tight glucose control significantly reduces this risk.
• Diabetic ketoacidosis (DKA): DKA can develop more rapidly in pregnancy and poses serious risks to the fetus. Sick-day management plans and prompt medical care are essential.
• Congenital anomalies: Poor glucose control in the first trimester is associated with higher rates of birth defects. Optimizing HbA1c before conception (ideally below 6.5%) reduces this risk.
• Preterm birth: Women with Type 1 diabetes have higher rates of preterm delivery, making regular prenatal monitoring crucial.

Pre-Conception Planning Is Essential

The best outcomes begin before conception. Women with Type 1 diabetes are strongly encouraged to work with their healthcare team before attempting to become pregnant. Goals include achieving an HbA1c as close to target as safely possible, reviewing and adjusting medications, starting folic acid supplementation, and screening for diabetes-related complications such as nephropathy and retinopathy, which can worsen during pregnancy.

Building Your Care Team

Managing Type 1 diabetes in pregnancy is truly a team effort. An ideal care team includes an endocrinologist, obstetrician or maternal-fetal medicine specialist, diabetes educator, registered dietitian, and mental health support. Regular appointments — often every one to two weeks — allow for frequent dose adjustments and monitoring of both maternal and fetal well-being.

Final Thoughts

Pregnancy with Type 1 diabetes requires extra effort, but modern tools like CGM and advanced insulin therapies have made safer pregnancies more achievable than ever before. With the right team, careful planning, and consistent monitoring, women with Type 1 diabetes can look forward to welcoming healthy babies into the world.